These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12515075)

  • 1. Use of radiation in the treatment of age-related macular degeneration.
    Flaxel CJ
    Ophthalmol Clin North Am; 2002 Dec; 15(4):437-44, v. PubMed ID: 12515075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
    Emerson MV; Lauer AK
    BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy for choroidal neovascularization in age-related macular degeneration. A pilot study using low- versus high-dose photon bean radiation].
    Thölen AM; Meister A; Bernasconi PP; Messmer EP
    Ophthalmologe; 1998 Oct; 95(10):691-8. PubMed ID: 9828635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of patients presenting with neovascular age-related macular degeneration in an urban population.
    Zawinka C; Ergun E; Stur M
    Retina; 2005; 25(3):324-31. PubMed ID: 15805910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration.
    Barak A; Hauser D; Yipp P; Morse L; Leigh B; Kubo D; Goldberg Z; Earle J; Handa JT
    Br J Radiol; 2005 Sep; 78(933):827-31. PubMed ID: 16110105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of antiangiogenic agents in age related macular degeneration].
    Tomi A
    Oftalmologia; 2010; 54(4):63-72. PubMed ID: 21516865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia].
    Simon P; Glacet-Bernard A; Coscas G; Soubrane G
    J Fr Ophtalmol; 2002 Sep; 25(7):694-700. PubMed ID: 12399725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.
    Haddad WM; Coscas G; Soubrane G
    Br J Ophthalmol; 2002 Jun; 86(6):663-9. PubMed ID: 12034690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Abrams P
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H; Pawelka I; Frohner U; Kruger A; Li W; Tewari HK
    Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy in exudative age-related macular degeneration.
    Figurska M; Wierzbowska J; Robaszkiewicz J
    Klin Oczna; 2010; 112(7-9):223-9. PubMed ID: 21117365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2004 Jun; (11):819-34. PubMed ID: 15652038
    [No Abstract]   [Full Text] [Related]  

  • 18. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2003 Dec; (10):727-43. PubMed ID: 15555119
    [No Abstract]   [Full Text] [Related]  

  • 19. Age related macular degeneration.
    Arnold J
    Clin Evid; 2005 Jun; (13):762-75. PubMed ID: 16135278
    [No Abstract]   [Full Text] [Related]  

  • 20. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.